Status:
COMPLETED
Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age
Lead Sponsor:
Murielle Surquin
Conditions:
Covid19
Eligibility:
All Genders
90+ years
Brief Summary
SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ran...
Eligibility Criteria
Inclusion
- Be over 90 years of age on the date of admission to CHU Brugmann Hospital
- Have a SARS Cov2 infection proven by antigen or RT-PCR on smear and / or typical imaging regardless of the clinical manifestation
- Have been hospitalized at CHU Brugmann between 03/01/2020 and 05/10/2020
Exclusion
- None
Key Trial Info
Start Date :
June 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04499300
Start Date
June 9 2020
End Date
November 23 2020
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium